Order results by:
| Issue | Title | |
| Vol 18, No 5 (2022) | The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case | Abstract similar documents |
| O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova | ||
| "... that, rosuvastatin 40 mg per day and ticagrelor 90mg 2 times a day were added to her therapy. During the current ..." | ||
| Vol 21, No 2 (2025) | Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case) | Abstract similar documents |
| A. V. Melekhov, S. V. Borisovskaya, N. S. Gavrilina, I. I. Gaponova, I. G. Nikitin, O. A. Ettinger | ||
| "... to chronic myopathy with severe weakness and, in rare cases, rhabdomyolysis with release of cellular ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... Aim. To study the effect of replacing clopidogrel with ticagrelor on endpoints of hospital period ..." | ||
| Vol 11, No 1 (2015) | MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova | ||
| "... for their withdrawal. Its severity can range from asymptomatic increase of serum CPK to life-threatening rhabdomyolysis ..." | ||
| Vol 13, No 4 (2017) | PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW | Abstract similar documents |
| I. S. Yavelov | ||
| "... , ticagrelor, in patients with high risk of thrombotic complications of atherosclerosis with a history ..." | ||
| Vol 8, No 4 (2012) | ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin | ||
| "... agents is discussed, especially this for ticagrelor which is the first-line drug in acute coronary ..." | ||
| Vol 7, No 1 (2011) | NEW ANTIPLATELET DRUGS (PART 1) | Abstract similar documents |
| A. B. Sumarokov | ||
| "... antiplatelet drugs are on their way to clinical application — prasugrel, ticagrelor, elinogrel, inhibitors ..." | ||
| Vol 7, No 5 (2011) | NEW ANTIPLATELET DRUGS. PART 2 | Abstract similar documents |
| A. B. Sumarokov | ||
| "... are on their way to clinical application — prasugrel, ticagrelor , elinogrel, thromboxane receptor inhibitors ..." | ||
| Vol 13, No 6 (2017) | CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE | Abstract similar documents |
| A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina | ||
| "... .5%) patients received clopidogrel, 17 (16.5%) – ticagrelor. After therapy correction based on genotype GA ..." | ||
| Vol 16, No 6 (2020) | Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice? | Abstract similar documents |
| T. M. Uskach, A. S. Tereshchenko | ||
| "... . The new generation of inhibitors of P2Y12 platelet receptors (prasugrel and ticagrelor) provide more ..." | ||
| Vol 14, No 6 (2018) | P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva | ||
| "... with clopidogrel or ticagrelor was performed, as well as of all 3 P2Y12-receptor inhibitors among themselves ..." | ||
| Vol 10, No 3 (2014) | THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW | Abstract similar documents |
| D. A. Napalkov | ||
| "... , myopathy and rhabdomyolysis, the impact on the diabetes and cognitive dysfunction onset, renal function ..." | ||
| Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. V. Rudakova, N. V. Lomakin | ||
| "... the prescription of new antiplatelet drugs, particularly the combination of ticagrelor with aspirin. Aim ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... on rosuvastatin. Data of recent metaanalysis regarding statins efficacy in primary and secondary prevention ..." | ||
| Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
| A. N. Meshkov | ||
| "... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..." | ||
| Vol 14, No 4 (2018) | Statin Therapy and Cognitive Impairment: Benefit or Harm? | Abstract similar documents |
| O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova | ||
| "... and reducing the risk of potential cognitive impairment during statin therapy. Rosuvastatin may be safer ..." | ||
| Vol 18, No 2 (2022) | The problem of choice: original drug or generic? Emphasis on rosuvastatin | Abstract similar documents |
| O. A. Polyakova, O. D. Ostroumova | ||
| "... is described by the example of such a hypolipidemic agent as rosuvastatin. According to numerous studies ..." | ||
| Vol 18, No 4 (2022) | Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review | Abstract similar documents |
| S. R. Gilyarevsky, M. V. Golshmid, N. G. Bendeliani | ||
| "... and rosuvastatin on blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) in hypertensive patients ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..." | ||
| Vol 5, No 2 (2009) | OBSERVATIONAL TRAILS IN LIPIDOLOGY | Abstract similar documents |
| S. A. Shalnova | ||
| Vol 7, No 1 (2011) | ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? | Abstract similar documents |
| L. N. Malay | ||
| "... Clinical cases of long-term use of rosuvastatin are presented with an estimation of its effect ..." | ||
| Vol 7, No 4 (2011) | USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING | Abstract similar documents |
| A. T. Abdrashitova, T. N. Panova, I. A. Belolapenko, M. V. Frenkel | ||
| "... for pathogenetic way for aging process deceleration. Aim. To study the geroprotective properties of rosuvastatin ..." | ||
| Vol 8, No 3 (2012) | STATINS AND MYOPATHY: MOLECULAR MECHANISMS | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova, O. N. Korneeva | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... the benefits of rosuvastatin in the prevention and treatment of cardiovascular diseases are presented. ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
| A. N. Meshkov | ||
| "... and well tolerated. Serious side effects due to atorvastatin use (myopathy and rhabdomyolysis) are very ..." | ||
| Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
| O. M. Drapkina, A. S. Lishuta | ||
| "... perindopril,rosuvastatin and fixed-dose combination of perindopril and indapamide, in ambulatory patients ..." | ||
| Vol 10, No 5 (2014) | EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova | ||
| "... Aim. To study the efficacy of rosuvastatin in dyslipidemia correction in patients after Q-wave ..." | ||
| Vol 3, No 5 (2007) | WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”? | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... Whether the study on efficacy of rosuvastatin in elderly patients with heart failure and systolic ..." | ||
| Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
| O. M. Drapkina | ||
| "... -lowering therapy with rosuvastatin, and to assess the level of satisfaction of doctors with the efficacy ..." | ||
| Vol 13, No 3 (2017) | TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 | Abstract similar documents |
| O. M. Drapkina, A. S. Luishuta | ||
| "... , including its combinations, and rosuvastatin in real clinical practice. Material and methods. Analysis ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... .5%, whereas prescription of atorvastatin and rosuvastatin increased from 31.4% to 64.5% and from 3.6% to 9 ..." | ||
| Vol 16, No 2 (2020) | Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG | Abstract similar documents |
| O. V. Fedorishina, K. V. Protasov, A. M. Torunova | ||
| "... antihypertensive therapy and additionally rosuvastatin (20 mg/day). The follow-up period was 52 weeks. The effect ..." | ||
| Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
| "... or rosuvastatin was recommended for all patients. To assess adherence the following surveys were used: medical ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... and rosuvastatin in an individually prescribed dose. After 1 month (B1), if the target level of lowdensity ..." | ||
| Vol 14, No 2 (2018) | WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| M. Yu. Gilyarov, Е. V. Konstantinova | ||
| "... as the second component of dual antiplatelet therapy, the possibility of prasugrel or ticagrelor usage should ..." | ||
| Vol 20, No 5 (2024) | Postmyocardial syndrome after myocardial infarction and percutaneous coronary intervention | Abstract similar documents |
| A. A. Klimenko, N. A. Demidova, V. V. Veselkin, T. A. Kirdyashkina, A. A. Chinova, Yu. A. Shandanovina | ||
| "... . Hospital treatment was carried out with colchicine, methylprednisolone, acetylsalicylic acid, ticagrelor ..." | ||
| Vol 17, No 4 (2021) | Epidemiological Observational Study on the Assessment of the Comorbidity and the Efficacy of the Treatment of Hypertensive Patients with Single Pill Combination of Lysinopril, Amlodipine and Rosuvastatin "PHENOTYPE-AG" | Abstract similar documents |
| M. P. Savenkov, S. N. Ivanov, M. V. Borschevskaya, I. N. Okuneva, S. V. Ivanova, A. M. Savenkova, R. V. Dushkin | ||
| "... , amlodipine and rosuvastatin (SPC LAR) in hypertensive patients. Material and methods. Observational ..." | ||
| Vol 15, No 2 (2019) | The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention | Abstract similar documents |
| A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov | ||
| "... inhibitors. Such platelet P2Y12-receptor inhibitors include ticagrelor and prasugrel. The article considers ..." | ||
| Vol 8, No 2 (2012): | РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ ОСТРОГО КОРОНАРНОГО СИНДРОМА БЕЗ СТОЙКОГО ПОДЪЕМА СЕГМЕНТА ST | Abstract similar documents |
| , , , , , , , , , , , , , , , , | ||
| Vol 19, No 2 (2023) | Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) | Abstract similar documents |
| M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov | ||
| "... .2% of cases, free combination of rosuvastatin with ezetimibe – in 17.2%, single pill combination ..." | ||
| Vol 14, No 5 (2018) | Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) | Abstract similar documents |
| G. S. Krasnov, I. V. Kazancev | ||
| "... +rosuvastatin, warfarin+amiodarone. It was found that the patient had not taken rosuvastatin before ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..." | ||
| Vol 16, No 5 (2020) | Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy? | Abstract similar documents |
| Z. D. Kobalava, E. V. Kokhan | ||
| "... combination of indapamide, perindopril and rosuvastatin, the requirements for fixed drug combinations ..." | ||
| Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
| I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
| "... groups: group 1 (n=64) received a single pill combination of lisinopril + amlodipine + rosuvastatin; 2 ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... are the cheapest among generics – about 17 rubles. The most expensive treatment with generics of rosuvastatin ..." | ||
| Vol 21, No 2 (2025) | A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol | Abstract similar documents |
| K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova | ||
| "... pitavastatin at a starting dose of 1 mg/day. Group 2 (n=75) will receive rosuvastatin 20 mg/day. After 3 months ..." | ||
| Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..." | ||
| Vol 17, No 3 (2021) | Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects | Abstract similar documents |
| P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina | ||
| "... of three components (lisinopril, amlodipine and rosuvastatin), each of which has pleiotropic effects ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
| "... with rosuvastatin. Target level of total cholesterol (<4 mmol/L) was achieved in 2.04-7.38% of the patients ..." | ||
| Vol 15, No 6 (2019) | Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice | Abstract similar documents |
| D. A. Napalkov | ||
| "... /perindopril, amlodipine/indapamide/perindopril and rosuvastatin in patients with hypertension and high/very ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... atorvastatin (10-80 mg/day) or rosuvastatin (10-40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
| Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
| S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
| "... atorvastatin (10-80 mg/day) or rosuvastatin (10- 40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... .2-5.3 (p<0.001). Doctors preferred atorvastatin in prescriptions (n=456, 55.4%), rosuvastatin (n=244 ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..." | ||
| 1 - 57 of 57 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
